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The EMBO Journal REFEREE REPORTS:
Referee #1 (General Remarks):
By combining genetic approaches and optical sectioning microscopy, the authors identify two new structures of developing lymphatic system: the dorsal peripheral longitudinal lymphatic vessel and the ventral primordial thoracic duct . The description is rigorous and the figures shown are largely informative. However the use of Cxcr4 and CCBE1 null mice are not sufficient to describe a solid mechanism explaining the formation of these structures. I suggest to extend the behavior of pTD and PLLV in Prox1 and VEGFR3 or VEGF-C null mice. Furthermore most of the data shown should be connected to and supported by morphometric analyses of the phenomena described.
To better support the concept underlined in the II paragraph of page 6 I suggest to show embryos at 9.5 and 10.5 at low magnification as in panel A and B of fig 1 with endomucin and Prox1 both associated with PECAM. Referee #2 (General Remarks):
H‰gerling & Pollmann et al. present an impressive amount of beautiful images depicting early stages of lymphatic vascular development in E9.5-12 mouse embryos. In contrast to recent results of Francois et al., this works shows that lymphatic endothelial cells, arising in the cardinal vein, exit as strings of migratory spindle-shaped cells. These cells, which have higher expression of Nrp2, Prox1 and Vegfr3, then coalesce into a mesh-like network and further condense into two large vessels, a peripheral longitudinal lymphatic vessel, from which secondary more superficial structures arise, and a primordial thoracic duct, connected to the vein via a lymphaticovenous valve.
The study also describes the expression of some known lymphatic markers during the different early steps that give birth to the lymphatic vascular network.
The technique is further used to analyse Ccbe1-/-embryos, which are known not to develop definitive lymphatic structures. As reported earlier, Prox1+/Vegfr-3+ lymphatic endothelial cells are shown to emerge in the cardinal vein. A new finding of this work is that there are ectopic Prox1+ cells in ISVs and some of these cells are still able to form rudimentary lymphatic vascular structures at very early stages, which then disappear later, as these presumptive lymphatic endothelial cells die. Still, the majority of lymphatic endothelial cells seem unable to bud and remain in the venous wall before disappearing. More interestingly, in the absence of Ccbe1 expression of Vegfr-3 is not extinguished in venous endothelium, and there is aberrant sprouting from this vascular compartment.
Finally, lymphatic vasculature in Cxcr4-/-embryos is analysed. In contrast to zebrafish, inactivation of Cxcr4 in mouse does not affect early steps of lymphatic vascular development, but the dermal lymphatic vessels display an abnormal patterning at E14.5.
The manuscript contains very nice images and it reports detailed high-resolution analysis of early lymphatic vascular development. Until now this process was only studied using OPT, a technique with much lower resolution, and coronal sections (Francois et al., Dev Biol., 2011), which apparently led to somewhat erroneous conclusions. Therefore, the data of H‰gerling et al. are important because they provide a hopefully definitive morphological description of the process. However, in the current format the manuscript is too complicated, contains too many redundant images and it is rather difficult to understand. Study of the expression of some selected lymphatic vascular markers is descriptive and does not add much to better understanding of the molecular events involved. In contrast, very interesting phenotype of Ccbe1 deficient mice is described only briefly. More detailed comments are outlined below: MAJOR REMARKS In any case, this part needs to be better structured and presented more clearly 7. CXCR4 story does not really fit with the other parts of the study, which focuses on the very early steps of lymphatic vascular development. At E14.5 in the skin the lymphatic developing vasculature is still growing as an immature primary plexus and the differentiation into capillary and collecting vessels is therefore difficult to visualize at that early stage. Given a rather superficial characterization of Cxcr4 knockout phenotype, this part can be removed without affecting main message (and perhaps published separately after more detailed analysis).
Minor remarks 1. The paragraph at the beginning of Resuts secrion describing microscopy is very technical, I suggest to shift it to the Materials and Methods. 2. Some paragraphs of the discussion are redundant with the results part and some others are not strictly related to this study (e.g. lumen formation, interendothelial junctions...). Again, re-writing to focus on the most relevant points will be necessary. 3. The text is full of abbreviations, which makes reading difficult. 4. The superposition of colors in images is often difficult to understand, and therefore many of them have mainly esthetical value. One could co-present also B&W pictures of the main staining of the complicated images, to help the reader convincingly visualize the important point. 5. Delineation of the CCVs missing on figure 6B.
Referee #3 (General Remarks):
This manuscript brings the power of optical sectioning microscopy approaches to analysis of the early stages of development of the lymphatic vasculature. In-so-doing it reports multiple discoveries including new insight into the role of Ccbe1 in lymphatic development, and the first characterisation of two separate lymphatic vessels that have so far been collectively referred to as the lymph sacs. The manuscript presents very high quality and thorough work in a clear fashion. This work significantly enhances our understanding of early lymphatic development and will likely be considered a "platform" for future studies into molecular and anatomical aspects of the development and function of the lymphatic vasculature. I have no major criticisms of the study and list a few minor points below. Specific responses to the reviewers' comments
We thank the referees for their helpful and constructive comments, which were valuable in shaping an improved manuscript and which we were able to address in full. In the following, we describe in detail how we have addressed and incorporated the reviewers' suggestions:
Specific responses to the comments of referee #1
We are pleased about referee #1 judging that Furthermore most of the data shown should be connected to and supported by morphometric analyses of the phenomena described. We agree -to address this highly relevant point, we have now included a quantitative evaluation of the visual / optical information provided for many figures in the manuscript. In particular, we have included an extensive morphometric analysis of the shape and Prox1 expression of lymphatic progenitors leaving the cardinal vein (Fig 2) .
To better support the concept underlined in the II paragraph of page 6 I suggest to show embryos at 9.5 and 10.5 at low magnification as in panel A and B of fig 1 with endomucin and Prox1 both associated with PECAM.
The requested data have been included in Fig.1 C,D and as suppl. Fig.2 Figure 1 has been extensively rearranged. As pointed out above, the original figure 1T (which reported the nuclear aspect ratio i.e. length max/minor axis) has been replaced by an analysis, which provides precise morphometric data on the shape (Fig.2 D,E ellicticity vs sphericity) and Prox1 expression level (Fig.2 F,G) for the lymphatic progenitors remaining and emerging from the cardinal vein.
Fig 1T. How do the authors record the nuclear shape?

Page 7. "The transition was associated with a pronounced...in iLEC (...)." May the authors show that the shaped modified iLEC really increase the expression of VEGFR3, Nrp2 and Prox1? How do the authors support this claim. It is required to show an accurate morphometric analysis. Similar information have to be provided for the description of other gene expression modifications along the text.
We fully concur with the reviewer's notion and now provide quantitative morphometric data e.g. in Fig.2 fig s6) . We fully agree and as requested, we have extensively repeated the in vivo EdU-labelling experiments and now provide in the new supplementary Fig.8 data on mouse embryos from a wide range of developmental stages (from E9.5, E10.0 and E10.5 to E11.5). Equally surprising and interesting, at no time we did detect a burst in proliferation, suggesting that the massive appearance of iLECs between E10.0 and E10.5 is the direct consequence of rapid emigration from the venous sources rather than increased proliferation.
Fig 2. Which is the panel corresponding to scheme G? I suggest to show sLEC in the wholemount pictures. Alternatively, refer to fig 3C.
We have removed the scheme corresponding to Fig.2 G and in addition corrected our schematic representations such that they now exactly match the wholemount panels.
Fig 3B. Which the rationale for the use of Unc5B? Some of the explanation provided later in the text should be indicated here.
The staining for Unc5B was performed in search for molecular markers that might distinguish the different LEC populations, e.g. sLECs from iLECs forming the PLLV or pTD. An important question is the one for the positional cues that result in the formation of these first lymphatic structures. We follow the suggestion of reviewer #1 and have indicated these issues in the text.
Fig 4E. What is the PECAM positive "ring" near CV?
Due to their high Prox1 expression, arterial vessels appear in a perfectly orthogonal section as an intensely stained ring (red in this case). The vessel in question is an arterial vessel connecting to the subclavian artery. We refer referee #1 to supplemental Fig.3 , which provides an overview of the arterial vasculature around at the respective developmental stage.
In Fig 4F the authors describe the interaction between an arterial vessel and CV. This point should be discussed and a possible speculation of this role exploited.
We have included this point in the discussion page 16 and speculated about a possible inductive role of this vessel to the formation of the lymphovenous valves.
Fig 5I. Which is the quantitative basis of the score here reported?
The quantitative assessments in Fig.5 I (now Fig.6 I) are based on antibody stained serial cyrosections that were analysed using a confocal microscope Zeiss LSM780. Importantly, all quantitative statements are based on LEC populations present on the same section. While so some expression changes were very obvious, e.g. complete loss of a protein, others were measured by pixel evaluation of the average pixel luminosities of at least 20 cells. A description of this procedure has now been included in the methods section..
Page 10, first lines. Which is the rationale supporting that valves develop from these Prox1 positive structures? I suggest examining the presence of the contact described in fig 4 in Prox1 and VEGFR3 null mice.
This point raised by reviewer #1 is an important one. While we lack formal proof that these areas will develop into lymphatic valves, the following points provide compelling support for this assumption. We detected exceedingly high Prox1 expression only at the direct contact points between CV and pTD. These contact sites were formed by two layers of endothelial cells, both expressing Prox1. One layer was provided by pTD, the other by the CV. (1) High level Prox1 expression has been reported to be a hallmark of valve induction later during lymphatic vessel maturation (Norrmen et al., 2009 ) (Sabine et al., 2012) . (2) The anatomical position of the described contact points, corresponds to the position reported in a recent publication, which studied the formation of lymphatic valves (Srinivasan and Oliver, 2011) and corresponds to the contact sides between lymphatic vessels and subclavian veins in the adult (see suppl. Fig.3 ). In the publication by Srinivasan et al. paired sites of valve formation, exactly like we see them, were shown to be comprised of two layers of endothelium, both expressing Prox1. These areas of the prospective valves are the only sites were Prox1 expression is retained in the CV (Srinivasan et al., 2011) . (3) The onset of lymphatic function, which depends on the development of functional valves is reported shortly after the formation of the contact sites between pTD and CV (Planas-Paz et al., 2012).
Fig 6. To facilitate the reader I suggest showing again the schemes of wild type mice.
We agree and gladly include this graphical element also for the newly included Vegfc mutants.
Fig 7. Does Cxcr4 ablation modify PPLV condensation?
No it does not. However, due to the extensive revisions requested and the major concern of reviewer #2, we have decided to remove the analysis of the CXCR4 ko from this manuscript and instead (1) we included the analysis of Vegfr3 heterozygous and Vegfc -/-mice. VEGFR-3 and VEGF-C both fulfil essential functions in early lymphatic development and we therefore found their analysis fitting in the context of this manuscript. (2) We have substantially expanded our analysis of CCBE1 deficiency by including Vegfc x Ccbe1 double heterozygous mice.
OTHER POINTS
Fig 1a,B. I suggest to indicate CV not only in the legend but also in the panels.
We indicated the position of the CV in all subsequent and compound panels, however, we find it obstructive when painted into Fig.1 A,B .
Fig 7. The title of figure is confusing
We agree, in any case the figure has been replaced.
Fig 4B "Hear " is probably a mistake
Thank you for pointing this out, we have corrected the mistake.
Fig 1 , panel S. To this referee it is not clear which panel this scheme corresponds.
We have now indicated the relation of this scheme to panel 2B. Fig. 1M . Also we have removed a substantial amount of panels and reduced, as requested, the Ccbe1 lacZ data (now suppl. Fig.10 ) to three panels. We do, however, strongly feel that a further reduction of the number of images to half the original panels, would remove important and indispensable information from the manuscript. In particular, we feel very strongly about the low magnification overview images, which with unprecedented detail allow the reader to relate lymphangiogenesis to the entire developing embryo, which we feel is of tremendous value, as shown e.g. in suppl. figure 3 which allows the identification of a particular arterial structure, which would be close to impossible from a serial sectioning approach.
The final figure should contain the comparison of the previous and new scheme that authors propose for formation of early lymphatic vasculature.
Given the large amount of graphic material that had to be accommodated in this manuscript, we would like to focus on primary data here and postpone the generation of a scheme for later publications. Based on the referee's comments, we have re-written the description of the lymphatic markers. We welcome the suggestions and have included the additional marker proteins VEGFR-2, integrin b1 and a9 (suppl. Fig.6 ). We have extensively attempted to stain integrin a9, however, using a protocol that reproducibly detected a9 staining during the last third of mouse development, we were not able to visualize a9 during the earliest stages of lymph vessel development. We apologize if the reader might have been misled to assume that these findings were novel. As pointed out by referee #2 they have been reported previously and we have made this more clear and have included the relevant references on page 5 and 9 to clarify this fact. As pointed out in this reply above, we have addressed these issues by a significantly more in depth analysis of CCBE-1-deficient embryos. To briefly address the reviewer's questions: Our analysis suggested that Prox1 positive cells arise in the CV and ISVs as they do in wild type littermates. The fact that the Prox1-expression domain appeared expanded may simply reflect the incapacity of these cells to leave the CV. Their differentiation state in the CV appeared to be still plastic and they failed
Description of expression of lymphatic markers
Down regulation of Vegfr-3 in blood vessels
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